Track the Massimo Group stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €41.6m. The latest transaction was filed on 3 June 2025 (Attribution). Among the most active insiders: Sheffield Mark. All data is free.
22
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,280 of 27,612 companies
41.2
score / 100
Value
36
Quality
46
FCF yld-2.1%
Earn yld3.9%
EV/EBITDA21.4x
ROE12%
Gross mgn38%
Net mgn2.1%
Debt/EBITDA4.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Massimo Group is a company listed on the XNAS market, specializing in patient monitoring solutions. It focuses on improving healthcare through innovative technologies.